BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Art Pappas to participate at Foundation Sante Biotechnology Conference at Samos, Greece
News | 07. 11. 2008
